Outcomes of Recurrent Facial Palsy in Melkersson Rosenthal Syndrome

Wang, Junying; Li, Peizhong; Jin, Xin; Xu, Yu; Zhang, Xin

doi:10.1177/0003489414551981

Cited by 13 publications

(15 citation statements)

References 17 publications

(17 reference statements)

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Patient outcomes were assessed most frequently by House‐Brackmann (H‐B) grade, with other measures including acoustic stapedius reflexes, and FPRP(facial paralysis recovery profile)/FPRI(facial paralysis recovery index) ratios . After a follow‐up period of 6 months to 2 years, 58 patients had H‐B grade ≤ 4 and 14 had H‐B grade ≥ 5.…”

Section: Resultsmentioning

confidence: 99%

“…H‐B grade, the standard selected by the Facial Nerve Disorders (FND) Committee, is a gross grading system that includes items evaluating the sequelae of facial palsy, including contracture, synkinesis and spasm . Of the 27 included studies, only six evaluated H‐B grade as an outcome . Most of the included studies were performed prior to 1985, when H‐B grade was first introduced.…”

Section: Discussionmentioning

confidence: 99%

“…Ten articles mentioned patients having multiple recurrences, with a maximum of four recurrences reported (Table 2A). 4,5,12,16,[21][22][23][24][25] Four articles did not specify numbers of recurrences, dichotomizing patients with one or ≥2 recurrences. The likelihood of recurrence increased with the number of recurrences, with probabilities of recurrence after one, two and three recurrences being 0.19, 0.18 and 0.33, respectively.…”

Section: Number Of Recurrent Episodesmentioning

confidence: 99%

“…31,32 Of the 27 included studies, only six evaluated H-B grade as an outcome. [15][16][17][18][19][20] Most of the included studies were performed prior to 1985, when H-B grade was first introduced.…”

Section: H-b Grade the Standard Selected By The Facial Nerve Disordersmentioning

confidence: 99%

See 3 more Smart Citations

Recurrent Bell's palsy

Dong

Jung

et al. 2019

Clinical Otolaryngology

View full text Add to dashboard Cite

Objective Although recurrent facial palsy was first reported in 1871, the aetiology, definitions, classifications, pathogenesis, treatment options and prognosis have not been clearly determined. There have been no systematic reviews and meta‐analyses of recurrent Bell's palsy. The purpose of this study was to evaluate the clinical manifestations of recurrent Bell's palsy through a systematic review and meta‐analysis. Design The SCOPUS, PubMed, Cochrane Library and EBSCO databases were searched through 1 May 2018, using the search terms “recurrent Bell's palsy” and “recurrent facial palsy,” for studies involving patients with recurrent Bell's palsy. Reference lists of eligible studies were also reviewed. Results A search of titles and abstracts in these four databases identified 222 studies; of these, 27 studies, involving 1041 patients from 13 countries, were analysed. The mean percentage of patients who experienced recurrence of Bell's palsy ranged from 0.8% to 19.4%. Five studies that included 191 patients were included in the meta‐analysis. Conclusions Among patients previously affected by Bell's palsy, the mean incidence of recurrent Bell's palsy was 6.5%. Sidedness of recurrent disease, relative to the side of the original disease, had no effect on patient prognosis. Of all patients with Bell's palsy, 66.0% recovered completely, with the recovery rate lower in patients with recurrent than with primary Bell's palsy.

show abstract

Section: Resultsmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

Section: Number Of Recurrent Episodesmentioning

confidence: 99%

Section: H-b Grade the Standard Selected By The Facial Nerve Disordersmentioning

confidence: 99%

See 2 more Smart Citations

Recurrent Bell's palsy

Dong

Jung

et al. 2019

Clinical Otolaryngology

View full text Add to dashboard Cite

show abstract

“…Recurrent facial paralysis is seen in 10% of the cases. 11 Facial paralysis is seen in 30-90% of cases, and is associated with facial edema in 13-50% of cases. 5 In a series by Tang et al, facial paralysis was bilateral in 40% of the cases.…”

Section: Diagnostic Featuresmentioning

confidence: 99%

<p>Management Strategies of Melkersson-Rosenthal Syndrome: A Review</p>

Dhawan¹,

Saini²,

Singhi³

2020

IJGM

View full text Add to dashboard Cite

Melkerrson-Rosenthal syndrome is a rare disorder of unknown aetiology and characterized by the triad of oro-facial edema, facial nerve palsy, and furrowing of the tongue. Two or more of the above are essential for making a clinical diagnosis. The mainstay of treatment is corticosteroids. Intralesional triamcinolone acetonide may be used for the treatment of oro-facial edema. Another treatment option for oro-facial edema includes intralesional betamethasone, along with oral doxycycline. The review discusses the management strategies in Melkersson-Rosenthal syndrome.

show abstract